Sun Pharma, India’s pharmaceutical giant, has elevated Aalok Shanghvi, the son of Dilip Shanghvi, chairman and managing ...

Alembic's revenue from operations rose to Rs 1,692.74 crore in Q3FY25, a 3.8 per cent Y-o-Y increase from Rs 1,630.57 crore ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

HFCL, Gland Pharma, Garden Reach Shipbuilders & Engineers, Premier Energies, Tata Chemicals, Castrol India, and NLC India, ...

Indian generic injectables maker Gland Pharma reported a 7% rise in third-quarter profit on Monday, as lower expenses helped mitigate the impact from production issues at its French unit Cenexi.

HYDERABAD/BENGALURU (Reuters) -Sun Pharmaceutical, India's largest drugmaker by revenue, reported a bigger-than-expected ...

Today, companies including Religare Enterprises, Gland Pharma, Fortis Malar Hospitals, Aditya Birla Capital, Alembic Pharma, ...

The Union Budget 2025 presents an opportunity to propel this sector toward innovation, self-reliance, and global ...

The Nifty Pharma index fell nearly 3% in intraday trade on January 28, marking its third consecutive session of decline, with ...

Results: Sun Pharmaceutical Industries on Friday said its consolidated net profit increased 15 per cent on-year to Rs 2,903 ...

Ahmedabad: A 32-year-old man from the Naranpura area of the city fell victim to an online fraud of Rs 9 lakh after being ...